PL210282B1 - New (4aR,7R)-(-)-4,4a,5,6,7,8-hexahydro-7ß-hydroxyl-4a-methyl-2-(3H)-naphtalenone and method for its manufacture - Google Patents

New (4aR,7R)-(-)-4,4a,5,6,7,8-hexahydro-7ß-hydroxyl-4a-methyl-2-(3H)-naphtalenone and method for its manufacture

Info

Publication number
PL210282B1
PL210282B1 PL378554A PL37855405A PL210282B1 PL 210282 B1 PL210282 B1 PL 210282B1 PL 378554 A PL378554 A PL 378554A PL 37855405 A PL37855405 A PL 37855405A PL 210282 B1 PL210282 B1 PL 210282B1
Authority
PL
Poland
Prior art keywords
hexahydro
methyl
naphthalenone
new
hydroxy
Prior art date
Application number
PL378554A
Other languages
Polish (pl)
Other versions
PL378554A1 (en
Inventor
Jadwiga Dmochowska-Gładysz
Tomasz Janeczko
Original Assignee
Univ Przyrodniczy We Wrocławiu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Przyrodniczy We Wrocławiu filed Critical Univ Przyrodniczy We Wrocławiu
Priority to PL378554A priority Critical patent/PL210282B1/en
Publication of PL378554A1 publication Critical patent/PL378554A1/en
Publication of PL210282B1 publication Critical patent/PL210282B1/en

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Description

Przedmiotem wynalazku jest nowy (4aR,7R)-(-)-4,4a,5,6,7,8-heksahydro-7e-hydroksy-4a-metylo-2-(3H)-naftalenon, o wzorze 2 przedstawionym na rysunku, i sposób jego wytwarzania.The subject of the invention is a new (4aR, 7R) - (-) - 4,4a, 5,6,7,8-hexahydro-7e-hydroxy-4a-methyl-2- (3H) -naphthalenone, with the formula 2 shown in the figure and the method of its production.

Związek ten może znaleźć zastosowanie, jako chiralny substrat w totalnej syntezie związków o wysokiej aktywności biologicznej, np. terpenoidów oraz steroidów.This compound may find use as a chiral substrate in the total synthesis of compounds with high biological activity, e.g. terpenoids and steroids.

W dostępnej literaturze nie znaleziono doniesień o otrzymaniu (4aR,7R)-(-)-4,4a,5,6,7,8-heksahydro-7e-hydroksy-4a-metylo-2(3H)-naftalenonu.There are no reports of obtaining (4aR, 7R) - (-) - 4,4a, 5,6,7,8-hexahydro-7e-hydroxy-4a-methyl-2 (3H) -naphthalenone in the available literature.

Istotą wynalazku jest nowy (4aR,7R)-(-)-4,4a,5,6,7,8-heksahydro-7e-hydroksy-4a-metylo-2(3H)-naftalenon, o wzorze 2 przedstawionym na rysunku.The essence of the invention is a new (4aR, 7R) - (-) - 4,4a, 5,6,7,8-hexahydro-7e-hydroxy-4a-methyl-2 (3H) -naphthalenone, represented by the formula 2 shown in the drawing.

Istotą wynalazku jest też sposób wytwarzania nowego (4aR,7R)-(-)-4,4a,5,6,7,8-heksahydro-7e-hydroksy-4a-metylo-2-(3H)-naftalenonu. Sposób, według wynalazku, polega na tym, że regioselektywną hydroksylację (R)-(-)-4,4a,5,6,7,8-heksahydro-4a-metylo-2-(3H)-naftalenonu prowadzi się za pomocą kultury szczepu Chaetomium sp. 1.The essence of the invention is also the method of producing new (4aR, 7R) - (-) - 4,4a, 5,6,7,8-hexahydro-7e-hydroxy-4a-methyl-2- (3H) -naphthalenone. The method according to the invention consists in that the regioselective hydroxylation of (R) - (-) - 4,4a, 5,6,7,8-hexahydro-4a-methyl-2- (3H) -naphthalenone is carried out with a culture Chaetomium sp. 1 strain.

Korzystne jest, gdy hydroksylację prowadzi się wodną kulturą szczepu, przy ciągłym mieszaniu reagentów, w temperaturze 288 - 308 K.It is preferable that the hydroxylation is carried out with the aqueous strain, under constant stirring of the reactants, at a temperature of 288-308 K.

Postępując zgodnie z wynalazkiem, w wyniku działania układu enzymatycznego zawartego w komórkach grzyba Chaetomium sp. 1, następuje regioselektywna hydroksylacja substratu w pozycji 7β. Uzyskany w ten sposób produkt wydziela się z wodnej kultury mikroorganizmu znanym sposobem przez ekstrakcję chloroformem.Proceeding according to the invention, as a result of the action of the enzyme system contained in the Chaetomium sp. 1 fungal cells, regioselective hydroxylation of the substrate in the 7β position takes place. The product obtained in this way is separated from the aqueous culture of the microorganism by a known method by extraction with chloroform.

Będący przedmiotem wynalazku (4aR,7R)-(-)-4,4a,5,6,7,8-heksahydro-7e-hydroksy-4a-metylo-2-(3H)-naftalenon może znaleźć zastosowanie np. jako chiralny substrat w totalnej syntezie bardziej skomplikowanej związków o wysokiej aktywności biologicznej z grupy: steroidów, alkaloidów oraz terpenoidów (M. Pufa, G. Revial, A. Gumgant, J. d'Angelo; J. Am. Chem. Soc, 1986, vol. 107).The (4aR, 7R) - (-) - 4,4a, 5,6,7,8-hexahydro-7e-hydroxy-4a-methyl-2- (3H) -naphthalenone being the subject of the invention can be used e.g. as a chiral substrate in the total synthesis of more complex compounds with high biological activity from the group of: steroids, alkaloids and terpenoids (M. Pufa, G. Revial, A. Gumgant, J. d'Angelo; J. Am. Chem. Soc, 1986, vol. 107 ).

Zasadniczą zaletą wynalazku jest otrzymanie (4aR,7R)-(-)-4,4a,5,6,7,8-heksahydro-7e-hydroksy-4a-metylo-2-(3H)-naftalenonu jako głównego produktu reakcji, z wydajnością 50%, w temperaturze pokojowej i pH bliskim obojętnemu.The main advantage of the invention is the preparation of (4aR, 7R) - (-) - 4,4a, 5,6,7,8-hexahydro-7e-hydroxy-4a-methyl-2- (3H) -naphthalenone as the main reaction product, 50% yield, at room temperature and near neutral pH.

Wynalazek jest bliżej objaśniony na przykładzie wykonania.The invention is explained in more detail using an exemplary embodiment.

P r z y k ł a d. Do kolby Erlenmajera o pojemności 250 cm3, w której znajduje się 100 cm3 sterylnej pożywki zawierającej 3 g glukozy i 1 g aminobaku, wprowadza się szczep Chaetomium sp. 1. Po trzech dniach wzrostu dodaje się 50 mg (R)-(-)-4,4a,5,6,7,8-heksahydro-4a-metylo-2(3H)-naftalenonu, o wzorze 1, rozpuszczonego w 1 cm3 acetonu. Transformację prowadzi się przy ciągłym wstrząsaniu przez 6 dni. Następnie uzyskany roztwór transformacyjny ekstrahuje się trzykrotnie chloroformem, osusza bezwodnym siarczanem magnezu i odparowuje rozpuszczalnik. Otrzymuje się 61 mg surowego produktu, który oczyszcza się chromatograficznie, jako eluentu używa się mieszaniny heksan-aceton, w stosunku 2:1. Na tej drodze otrzymuje się 25,2 mg (4aR,7R)-(-)-4,4a,5,6,7,8-heksahydro-7e-hydroksy-4a-metylo-2-(3H)-naftalenonu (wydajność przekracza 50%).Example d. To the Erlenmeyer flask with a capacity of 250 cm 3, which is 100 cm 3 of sterile medium containing 3 g of glucose and 1 g aminobaku introduced into a strain of Chaetomium sp. 1. After three days of growth is added 50 mg of ( R) - (-) - 4,4a, 5,6,7,8-hexahydro-4a-methyl-2 (3H) -naphthalenone of formula 1, dissolved in 1 cm 3 of acetone. The transformation is carried out under continuous shaking for 6 days. The resulting transformation solution was then extracted three times with chloroform, dried with anhydrous magnesium sulfate, and the solvent was evaporated. 61 mg of crude product are obtained, which product is purified by chromatography using a 2: 1 hexane-acetone mixture as eluent. In this way, 25.2 mg of (4aR, 7R) - (-) - 4.4a, 5,6,7,8-hexahydro-7e-hydroxy-4a-methyl-2- (3H) -naphthalenone are obtained (yield exceeds 50%).

Uzyskany produkt charakteryzuje się następującymi danymi spektralnymi:The obtained product is characterized by the following spectral data:

1H NMR (500 MHz, CDCI3) δ (ppm); 1,21 (s, 3H); 1,34 (td, 1H, J = 14,4 Hz, J = 3,6Hz); 1,62-1,81 (m, 4H); 1,87-1,92 (m, 1H); 2,38-2,36 (m, 3H); 2,46 (ddd, 1H, J = 17,1 Hz, J = 14,0 Hz, J = 5,6 Hz); 2,51 (ddd, 1H, J = 14,0 Hz, J = 4,6 Hz, J = 2,5 Hz); 3,57 (tt, 1H, J = 11,1 Hz, J = 4,8 Hz); 5,72 (s, 1H). 1 H NMR (500 MHz, CDCl 3) δ (ppm); 1.21 (s. 3H); 1.34 (td, 1H, J = 14.4Hz, J = 3.6Hz); 1.62-1.81 (m, 4H); 1.87-1.92 (m, 1H); 2.38-2.36 (m, 3H); 2.46 (ddd, 1H, J = 17.1 Hz, J = 14.0 Hz, J = 5.6 Hz); 2.51 (ddd, 1H, J = 14.0 Hz, J = 4.6 Hz, J = 2.5 Hz); 3.57 (mp, 1H, J = 11.1Hz, J = 4.8Hz); 5.72 (s, 1H).

Claims (4)

1. Nowy (4aR,7R)-(-)-4,4a,5,6,7,8-heksahydro-7e-hydroksy-4a-metylo-2-(3H)-naftalenon, o wzorze 2.1. A new (4aR, 7R) - (-) - 4,4a, 5,6,7,8-hexahydro-7e-hydroxy-4a-methyl-2- (3H) -naphthalenone, of formula 2. 2. Sposób wytwarzania nowego (4aR,7R)-(-)-4,4a,5,6,7,8-heksahydro-7e-hydroksy-4a-metylo-2-(3H)-naftalenonu, o wzorze 2, na drodze transformacji mikrobiologicznej, znamienny tym, że jako substrat stosuje się (R)-(-)-4,4a,5,6,7,8-heksahydro-4a-metylo-2-(3H)-naftalenon, o wzorze 1, który poddaje się hydroksylacji za pomocą systemu enzymatycznego szczepu grzyba z gatunku Chaetomium sp. 1.2. The method of producing the new (4aR, 7R) - (-) - 4,4a, 5,6,7,8-hexahydro-7e-hydroxy-4a-methyl-2- (3H) -naphthalenone, formula 2, by microbial transformation, characterized in that the substrate is (R) - (-) - 4,4a, 5,6,7,8-hexahydro-4a-methyl-2- (3H) -naphthalenone, of the formula 1, which is hydroxylated with the enzyme system of the fungal strain Chaetomium sp. 1. 3. Sposób według zastrz. 1, znamienny tym, że proces regioselektywnej hydroksylacji substratu prowadzi się wodną kulturą szczepu przy ciągłym mieszaniu.3. The method according to p. The process of claim 1, wherein the process of regioselective hydroxylation of the substrate is carried out with an aqueous culture of the strain under continuous agitation. 4. Sposób według zastrz. 1, znamienny tym, że proces hydroksylacji substratu prowadzi się w temperaturze 288 - 308 K.4. The method according to p. The method of claim 1, characterized in that the substrate hydroxylation process is carried out at a temperature of 288-308 K.
PL378554A 2005-12-28 2005-12-28 New (4aR,7R)-(-)-4,4a,5,6,7,8-hexahydro-7ß-hydroxyl-4a-methyl-2-(3H)-naphtalenone and method for its manufacture PL210282B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL378554A PL210282B1 (en) 2005-12-28 2005-12-28 New (4aR,7R)-(-)-4,4a,5,6,7,8-hexahydro-7ß-hydroxyl-4a-methyl-2-(3H)-naphtalenone and method for its manufacture

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL378554A PL210282B1 (en) 2005-12-28 2005-12-28 New (4aR,7R)-(-)-4,4a,5,6,7,8-hexahydro-7ß-hydroxyl-4a-methyl-2-(3H)-naphtalenone and method for its manufacture

Publications (2)

Publication Number Publication Date
PL378554A1 PL378554A1 (en) 2006-06-26
PL210282B1 true PL210282B1 (en) 2011-12-30

Family

ID=38739820

Family Applications (1)

Application Number Title Priority Date Filing Date
PL378554A PL210282B1 (en) 2005-12-28 2005-12-28 New (4aR,7R)-(-)-4,4a,5,6,7,8-hexahydro-7ß-hydroxyl-4a-methyl-2-(3H)-naphtalenone and method for its manufacture

Country Status (1)

Country Link
PL (1) PL210282B1 (en)

Also Published As

Publication number Publication date
PL378554A1 (en) 2006-06-26

Similar Documents

Publication Publication Date Title
CN106188078A (en) A kind of chiral spiro hydroxyindole benzopyrone the synthetic method of 3,4 dihydropyrane compounds
PL210282B1 (en) New (4aR,7R)-(-)-4,4a,5,6,7,8-hexahydro-7ß-hydroxyl-4a-methyl-2-(3H)-naphtalenone and method for its manufacture
PL213614B1 (en) new 7-0-n-D-4 methoxyglucopiranozide 8- prenylonaringenines and the manner of their manfacturing
Wang et al. Synthesis of trifluoromethylated analogues of β-l-fucofuranose and β-l-4, 6-dideoxyxylohexopyranose
PL195347B1 (en) Method of manufacturing s(s+)-1,2,3,4-tetrahydro-1-naphtol
PL207190B1 (en) Method for manufacturing naphtalenone (4aS, 6S)-4,4a, 5,6,7,8-hexahydro-6-hydroxyl-4a-methyl-2 (3H)
PL223446B1 (en) 4'-O-β-D-glucopyranosylxanthohumol C and a method for its manufacturing
PL207193B1 (en) Method for the manufacture of (4aR,6R)-(-)-4,4a,5,6,7,8-hexahydro-6ß-hydroxyl-4a-methyl-2-(3H)-naphtalenone
PL207817B1 (en) Method for the manufacture of S-(-)-6-chloro-1, 2, 3, 4-tetrahydro-2-naphtol
PL223444B1 (en) Method for preparing 1",2",α,β-tetrahydroxanthohumol C
PL223441B1 (en) 4'-O-β-D-glucopyranosyl-4, 2'-dihydroxy-6'-methoxy-3'-prenyl-α, β-dihydrochalcone and a process for its preparation
PL207816B1 (en) Method for the manufacture of S-(-)-7-methoxy-1, 2, 3, 4-tetrahydro-2-naphtol
PL207814B1 (en) Production method of S-(-)-8-metoxy-2tetralol
PL207815B1 (en) Method for the manufacture of S-(-)-6-methoxy-1, 2, 3, 4-tetrahydro-2-naphtol
PL222788B1 (en) 4'-0-β-D-4'' '-methoxy-glucopyranosyl-4, 2'-dihydroxy-6'-methoxy-3'-prenyl-α, β-dihydrochalcone and a process for its preparation
PL197575B1 (en) Method for manufacture of s-(-)-1-(2-naphtyl)ethanol
PL192228B1 (en) Novel 8ß-hydroxy-1-dehydroandrostendione and method of obtaining same
PL207820B1 (en) Method for the obtainment of S-(+)-5-metoxy-1-tetralole
PL237132B1 (en) 7-O-β-D-4''-O-methyl-glucopyranosyl-3',4',5-trihydroxyflavanone and method for obtaining 7-O-β-D-4''-O-methyl-glucopyranosyl-3',4',5-trihydroxyflavanone
PL237131B1 (en) Method for obtaining 3'-O-β-D-glucopyranosyl-4',5.7-trihydroxyflavanone
PL215792B1 (en) (Z)-6-sulfate-6,4'-dihydroxy-7-prenyl-4-metoksyaurone and process for the preparation thereof
PL218593B1 (en) Process for obtaining of 4'-hydroxy-7,8-benzoflavone
PL207821B1 (en) Method for the manufacture of S-(-)-8-methoxy-1, 2, 3, 4-tetrahydro-2-naphtol
PL223442B1 (en) 4'-O-β-D-glucopyranosyl-1",2"-dihydroxanthohumol K and its manufacturing process
PL210638B1 (en) New 7-O- -D-4-isoxantohumol methoxyglucopyranozid and its production method

Legal Events

Date Code Title Description
LICE Declarations of willingness to grant licence

Effective date: 20110811

LAPS Decisions on the lapse of the protection rights

Effective date: 20081228